Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Korea's Celltrion Not Seeking More Sales, Distribution Deals With Big Pharma

Oct 10 2011

• By PharmAsia News

Related Content

Korea's Celltrion And Aprogen In Race To Sell Biosimilars In Japan

Nov 02 2010

Korea's Celltrion In Deal With U.S.-based Hospira For Biogeneric Sales; M&A Hinted At

Oct 12 2009

Korea's Celltrion Signs Deal with Hungary's Egis Pharmaceuticals to Sell Biosimilars In Former Soviet Republic Countries, Eastern Europe

Feb 08 2010

Celltrion Nearly Triples Production Capability For Biosimilars In Anticipation Of Global Launches

Sep 20 2011

Korea's Celltrion SVP Kim Hyoung-Ki On Gearing Up To Launch Biosimilars In Global Markets: An Interview With PharmAsia News

Sep 30 2011

Merck Lands Late-Stage Enbrel Biosimilar In Deal With South Korea's Hanwha

Jun 14 2011

Korea's Samsung Electronics On Manhunt For Biosimilar Talent As Local Companies Keep Wary Eye On Competition

Mar 26 2010

More from Archive

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window